Literature DB >> 25665738

Replication the association of 2q32.2-q32.3 and 14q32.11 with hepatocellular carcinoma.

Wei Chen1, Mingquan Wang2, Zhen Zhang1, Huayang Tang3, Xianbo Zuo3, Xiangling Meng1, Maoming Xiong1, Fusheng Zhou3, Bo Liang3, Fen Dai1, Jun Fang1, Jinping Gao3, Jun Zhu3, Yong Zhu1, Hong Wan1, Miaofeng Wang1, Shixin Chan1, Liangdan Sun4.   

Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor. The morbidity and mortality of HCC tend to ascend and become a serious threat to the population health. Genetic studies of HCC have identified several susceptibility loci of HCC. In this study, we aim to replicate the association of these loci in our samples from Chinese population and further investigate the genetic interaction. We selected 16 SNPs within 1p36.22, 2q32.2-q32.3, 3p21.33, 8p12, 14q32.11 and 21q21.3 and genotyped in 507 HCC patients and 3014 controls by using Sequenom MassARRAY system. Association analyses were performed by using PLINK 1.07. We observed that the STAT4 (2q32.2-q32.3) at rs7574865 (P=1.17×10(-3), OR=0.79) and EFCAB11 (14q32.11) at rs8013403 (P=1.54×10(-3), OR=0.80) were significantly associated with HCC in this study. In 3p21.33, genetic variant rs6795737 within GLB1 was also observed with suggestive evidence (P=9.98×10(-3), OR=0.84). In the interaction analysis, the pair of associated SNPs (rs7574865 within STAT4, rs8013403 within EFCAB11) generated evidence for interaction (P=4.10×10(-3)). In summary, our work first reported the association of 14q32.11 (EFCAB11) with HCC in Chinese Han population and revealed the genetic interaction between STAT4 (2q32.2-q32.3) and EFCAB11 (14q32.11) in HCC.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetics; Hepatocellular carcinoma; Polymorphism

Mesh:

Substances:

Year:  2015        PMID: 25665738     DOI: 10.1016/j.gene.2015.02.006

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis.

Authors:  Jianjun Li; Lu Liang; Yongru Liu; Yihuan Luo; Xiaona Liang; Dianzhong Luo; Zhenbo Feng; Yiwu Dang; Lihua Yang; Gang Chen
Journal:  Onco Targets Ther       Date:  2016-03-21       Impact factor: 4.147

2.  Systematic Review and Meta-Analysis on the Association between Polymorphisms in Genes of IL-12 Signaling Pathway and Hepatocellular Carcinoma Risk.

Authors:  Yao Xiao; Guodong Liu; Liansheng Gong
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

3.  Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Han Shi; Hongyan He; Suvash Chandra Ojha; Changfeng Sun; Juan Fu; Mao Yan; Cunliang Deng; Yunjian Sheng
Journal:  Biosci Rep       Date:  2019-06-20       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.